Additional Funded Research Projects

Michael H. Cohen has a role in the following funded research projects at HMS.

Credentialing Practices, Malpractice Liability Policies, and Guidelines Governing Recommendations Involving Dietary Supplements (2000-2002) (Co-Investigator): This project involved a detailed survey of nineteen U.S. hospitals with review of their policies concerning CAM therapies. The manuscript will be published in Archives of Internal Medicine.

Models of Integrative Care in an Academic Health Center (2001-2005) (Co-Investigator): This project involves development of model guidelines for credentialing providers, managing liability risk, and setting policy for dietary supplements in the integrative care clinical facility. The guidelines have been adapted by the HMS-affiliated hospital implementing the research arm of an NIH-funded integrative care clinic.

Legal and Social Barriers to Alternative Therapies (2002-2005) (Principal Investigator): This project uses qualitative and ethnographic research to prepare a scholarly, book-length manuscript that critically evaluates the integration of CAM therapies into conventional medical settings in the United States. A draft manuscript is out to publishers for evaluation.

International Center for CAM Research (2003-2005) (Co-Investigator): This project focuses on the systematic evaluation of East Asian herbal products. The grant includes development of the necessary administrative and legal infrastructure, including negotiation of a formal collaboration agreement to satisfactorily address issues of intellectual property, royalty sharing, publication procedures, and shared access to NIH resources.

Asian Herbal Products for Epilepsy (2004-2005) ) (Co-Investigator): This study involves investigation of promising herbs for treatment of epilepsy, with a focus on intellectual property issues pertinent thereto.

Pediatric Use of Complementary Therapies by Parents: Ethical and Policy Choices (2004-2005) (Principal Investigator): This study is researching and analyzing ethical and policy recommendations concerning parental choices involving CAM therapies for their children. The study will result in a published manuscript suggesting guidelines for state agencies, physicians, and judges in cases involving allegations of abuse and neglect concerning treatment through CAM therapies.